Evidence map›Paper›PMID 42078152›Full record

ArticleCureus2026

From Spreadsheet To Prediction Tool: A Practical Artificial Intelligence Guide For Urologists.

Ankit Joshi, Kinju Adhikari, Ravi Taori, Deepak Krishnappa, Aadhar Jain, Lingesh Chelliah, Layeeq Fatima, Raghunath Krishnappa

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ankit JoshiUro-Oncology and Robotic Surgery, HCG Cancer Centre, Bengaluru, IND.
Kinju AdhikariUro-Oncology and Robotic Surgery, HCG Cancer Centre, Bengaluru, IND.
Ravi TaoriUro-Oncology and Robotic Surgery, HCG Cancer Centre, Bengaluru, IND.
Deepak KrishnappaUro-Oncology and Robotic Surgery, HCG Cancer Centre, Bengaluru, IND.
Aadhar JainUro-Oncology and Robotic Surgery, HCG Cancer Centre, Bengaluru, IND.
Lingesh ChelliahUro-Oncology and Robotic Surgery, HCG Cancer Centre, Bengaluru, IND.
Layeeq FatimaUro-Oncology and Robotic Surgery, HCG Cancer Centre, Bengaluru, IND.
Raghunath KrishnappaUro-Oncology and Robotic Surgery, HCG Cancer Centre, Bengaluru, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) and machine learning (ML) are transforming urological practice; however, most clinicians lack the technical background required to develop, evaluate, or critically appraise predictive models. Existing resources are often written by data scientists for a technical audience, highlighting the need for a practical, clinician-oriented framework that enables urologists to build and deploy meaningful AI tools using data they already possess. Following an overview of the AI landscape in urology, we present a structured nine-part framework that includes clinical data appraisal; data cleaning and variable engineering; model selection (e.g., logistic regression, Random Forest, Extreme Gradient Boosting (XGBoost), and Cox regression); train-test splitting; cross-validation; performance evaluation (including area under the curve (AUC), calibration, and decision curve analysis); AI-assisted coding using platforms such as Google Colab and large language models (LLMs); web application deployment (e.g., Hugging Face, Gradio, GitHub, Render, and Google Cloud); manuscript preparation aligned with Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis-Artificial Intelligence (TRIPOD-AI) reporting standards; and ethical considerations for responsible AI deployment. Each component is illustrated with real-world examples and supported by validated prompt templates. Applying this framework to a high-risk prostate cancer cohort, the lead author, without prior programming experience, successfully developed and publicly deployed a validated multi-outcome prediction tool within 72 hours using entirely free, open-source infrastructure. AI-based clinical prediction tools are increasingly accessible to urologists with structured datasets and a systematic approach. This guide aims to democratize AI model development by enabling clinicians to extract actionable insights from existing data, build validated tools, and contribute meaningfully to the evolving landscape of AI-driven urological care, without the need to write code from scratch.

Indexed as

ai and machine learningartificial intelligence and medicinea urologist perspectivedata and analyticspredictive modelsurgical researchurology education

Identifiers

PMID42078152
PMCPMC13135452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.